Silicon Laboratories (SLAB) And Its IoT Story Leave Valuation Questions Open

Silicon Laboratories Inc.

Silicon Laboratories Inc.

SLAB

0.00

Silicon Laboratories stock snapshot after recent performance

Silicon Laboratories (SLAB) recently closed at $217.50, with the stock roughly flat over the past week and month. Returns over the past 3 months also appear broadly steady, while longer term performance remains stronger.

Silicon Laboratories shows strong longer term momentum, with a year to date share price return of 64.9% and a 1 year total shareholder return of 62.9%, even as very recent moves remain relatively muted.

If this kind of steady strength has your attention, it could be a good moment to broaden your watchlist with other AI focused chip players through the 55 AI infrastructure stocks

Silicon Laboratories combines a broad IoT chip footprint with strong multi year shareholder returns, yet the stock now sits near recent highs. The key question for investors is whether those business strengths still line up with a fair price today.

Most Popular Narrative: 2.4% Undervalued

The most followed narrative puts Silicon Laboratories' fair value at $222.86, only slightly above the recent $217.50 close, which keeps expectations tight around current pricing.

Ongoing rollout of new, highly integrated, energy-efficient wireless platforms (Series 2 and Series 3) positions Silicon Labs to capture increased market share and supports higher ASPs, which is likely to drive top-line growth and gross margin improvement. Growing adoption of battery-powered IoT and connected healthcare applications, enabled by the company's ultra-low-power wireless solutions, unlocks new, higher-value end markets and diversifies revenue streams, supporting improved earnings sustainability.

Want to see what kind of revenue path, margin profile, and future earnings multiple sit behind that fair value line? The narrative builds on compounded top line expansion, a margin shift from current losses, and a future valuation multiple that has to match those higher earnings. The exact mix of growth, profitability and discount rate assumptions is where the story really gets interesting.

Result: Fair Value of $222.86 (UNDERVALUED)

However, investors in Silicon Laboratories still need to weigh two key risks: slower IoT adoption and tougher competition that pressures pricing and crimps long term margins.

Another View on Silicon Laboratories valuation

The analyst narrative describes Silicon Laboratories as about 2.4% undervalued, with a fair value of $222.86 close to the $217.50 share price. However, on a simple P/S basis the picture is very different, with the stock at 8.7x versus 6.8x for the US Semiconductor industry and a fair ratio of 7.1x. If the market moves back toward that fair ratio, how comfortable are you with the valuation risk this gap implies?

NasdaqGS:SLAB P/S Ratio as at Aug 2026
NasdaqGS:SLAB P/S Ratio as at Aug 2026

Next Steps

With Silicon Laboratories sitting close to many investors fair value estimates, this is a good time to review the full picture yourself, from upside potential to possible downsides. To weigh both sides in one place, take a look at the 1 key reward and 2 important warning signs.

Looking for more investment ideas beyond Silicon Laboratories?

If you stop at Silicon Laboratories, you could miss other opportunities that fit your style. Use these focused ideas to round out your watchlist with intent and discipline.

  • Target potential mispricings by reviewing companies that screen as high quality and attractively valued through the 55 high quality undervalued stocks.
  • Strengthen your income stream by assessing businesses that feature resilient cash flows and higher yields in the 9 dividend fortresses.
  • Prioritise resilience by scanning for companies with robust balance sheets and solid fundamentals using the solid balance sheet and fundamentals stocks screener (45 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.